A Route to Lipid ALC-0315: a Key Component of a COVID-19 mRNA Vaccine
- PMID: 35665545
- PMCID: PMC9348069
- DOI: 10.1002/chem.202200906
A Route to Lipid ALC-0315: a Key Component of a COVID-19 mRNA Vaccine
Abstract
This paper describes a synthesis of ALC-0315 by a sequence that more than doubles the overall yield relative to the published one, and that employs much cleaner reactions, thereby facilitating purifications to a considerable extent.
Keywords: RNA therapeutics; lipids; reductive amination; vaccines.
© 2022 Wiley-VCH GmbH.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- S. M. Ansell, X. Du, US 10,166,298 B2 20190101.
-
- Corey E. J., Suggs J. W., Tetrahedron Lett. 1975, 16, 2647–2650.
-
- The formation of such byproducts may be due to the acidic nature of PCC. However, conduct of the PCC oxidation reaction in the presence of Na2CO3 failed to alleviate the problem.
-
- Review: Tidwell T. T., Org. React. 1990, 39. 297–572.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical